We, therefore, used Guanabenz (GBZ), a small compound with enhancing eIF2α phosphorylation activity to evaluate its effect on bacterial LPS sensing and endotoxemia. The gene discussed is EIF2A; the disease is serum lipopolysaccharide activity.